← Open Payments lookup

MO KEOVONGSA: Open Payments

NPI 1710157300 · BURLINGTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,425 in 109 payments from 23 companies in 2025. Trend: 2023 $116 · 2024 $3,920 · 2025 $2,425

Food & beverage: $2,425
CompanyPaymentsAmount
Salix Pharmaceuticals, a division of Bausch Health US, LLC23$386
ABBVIE INC.18$340
Regeneron Healthcare Solutions, Inc.6$288
Gilead Sciences, Inc.9$210
Takeda Pharmaceuticals U.S.A., Inc.10$172
Madrigal Pharmaceuticals4$157
PFIZER INC.8$152
Janssen Biotech, Inc.6$139
GENZYME CORPORATION5$131
QOL Medical, LLC3$84

Products named: XIFAXAN, DUPIXENT, RINVOQ, REZDIFFRA, XELJANZ, TREMFYA, CREON, ENTYVIO.

Industry payments across MA — which companies pay providers there.